Millennium Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.71M | Sell |
96,364
-1,851,131
| -95% | -$49.3M | ﹤0.01% | 3575 |
|
|
2025
Q4 | $48.5M | Buy |
1,947,495
+191,296
| +11% | +$4.82M | 0.02% | 838 |
|
|
2025
Q3 | $44.7M | Sell |
1,756,199
-12,237,392
| -87% | -$302M | 0.02% | 959 |
|
|
2025
Q2 | $339M | Buy |
13,993,591
+6,534,079
| +88% | +$152M | 0.16% | 75 |
|
|
2025
Q1 | $189M | Buy |
7,459,512
+4,420,708
| +145% | +$116M | 0.1% | 169 |
|
|
2024
Q4 | $80.6M | Sell |
3,038,804
-12,434,525
| -80% | -$337M | 0.04% | 494 |
|
|
2024
Q3 | $448M | Sell |
15,473,329
-4,448,515
| -22% | -$130M | 0.21% | 51 |
|
|
2024
Q2 | $557M | Buy |
19,921,844
+12,145,685
| +156% | +$334M | 0.26% | 46 |
|
|
2024
Q1 | $216M | Sell |
7,776,159
-1,759,324
| -18% | -$48.8M | 0.09% | 182 |
|
|
2023
Q4 | $275M | Buy |
9,535,483
+5,282,369
| +124% | +$160M | 0.12% | 117 |
|
|
2023
Q3 | $141M | Buy |
4,253,114
+2,639,318
| +164% | +$93.3M | 0.07% | 232 |
|
|
2023
Q2 | $59.2M | Buy |
1,613,796
+639,938
| +66% | +$24.9M | 0.03% | 630 |
|
|
2023
Q1 | $39.7M | Sell |
973,858
-150,750
| -13% | -$6.51M | 0.02% | 843 |
|
|
2022
Q4 | $57.6M | Sell |
1,124,608
-587,233
| -34% | -$28.2M | 0.03% | 675 |
|
|
2022
Q3 | $74.9M | Buy |
1,711,841
+1,587,540
| +1,277% | +$77.1M | 0.04% | 474 |
|
|
2022
Q2 | $6.52M | Sell |
124,301
-3,366,305
| -96% | -$172M | ﹤0.01% | 2516 |
|
|
2022
Q1 | $181M | Sell |
3,490,606
-809,178
| -19% | -$42M | 0.1% | 135 |
|
|
2021
Q4 | $254M | Sell |
4,299,784
-510,935
| -11% | -$25.3M | 0.13% | 109 |
|
|
2021
Q3 | $207M | Buy |
4,810,719
+6,957
| +0.1% | +$308K | 0.12% | 113 |
|
|
2021
Q2 | $188M | Buy |
4,803,762
+4,307,185
| +867% | +$167M | 0.12% | 111 |
|
|
2021
Q1 | $18M | Sell |
496,577
-2,411,489
| -83% | -$85.6M | 0.01% | 1185 |
|
|
2020
Q4 | $107M | Buy |
2,908,066
+1,516,687
| +109% | +$55.6M | 0.08% | 197 |
|
|
2020
Q3 | $48.4K | Sell |
1,391,379
-1,791,296
| -56% | -$62.8M | 0.06% | 331 |
|
|
2020
Q2 | $98.7M | Sell |
3,182,675
-239,279
| -7% | -$8.13M | 0.14% | 107 |
|
|
2020
Q1 | $106M | Sell |
3,421,954
-1,749,737
| -34% | -$59.6M | 0.24% | 55 |
|
|
2019
Q4 | $192M | Buy |
5,171,691
+398,448
| +8% | +$14.2M | 0.24% | 50 |
|
|
2019
Q3 | $163M | Buy |
4,773,243
+2,533,372
| +113% | +$92.1M | 0.26% | 48 |
|
|
2019
Q2 | $92.1M | Sell |
2,239,871
-2,460,143
| -52% | -$97.7M | 0.14% | 147 |
|
|
2019
Q1 | $189M | Buy |
4,700,014
+3,502,649
| +293% | +$140M | 0.28% | 32 |
|
|
2018
Q4 | $49.6M | Buy |
1,197,365
+1,020,574
| +577% | +$42.4M | 0.08% | 345 |
|
|
2018
Q3 | $7.39M | Sell |
176,791
-272,579
| -61% | -$10.5M | 0.01% | 1524 |
|
|
2018
Q2 | $15.5M | Sell |
449,370
-1,452,070
| -76% | -$49.6M | 0.02% | 1028 |
|
|
2018
Q1 | $64M | Sell |
1,901,440
-1,820,936
| -49% | -$62.6M | 0.09% | 332 |
|
|
2017
Q4 | $128M | Buy |
3,722,376
+1,132,388
| +44% | +$38.6M | 0.18% | 100 |
|
|
2017
Q3 | $87.7M | Buy |
2,589,988
+1,804,893
| +230% | +$58M | 0.13% | 157 |
|
|
2017
Q2 | $25M | Sell |
785,095
-536,780
| -41% | -$16.9M | 0.04% | 573 |
|
|
2017
Q1 | $42.9M | Buy |
+1,321,875
| New | +$41.7M | 0.08% | 357 |
|
|
2016
Q4 | – | Sell |
-1,454,977
| Closed | -$46.8M | – | 3625 |
|
|
2016
Q3 | $46.8M | Sell |
1,454,977
-81,241
| -5% | -$2.72M | 0.08% | 276 |
|
|
2016
Q2 | $51.3M | Buy |
1,536,218
+673,150
| +78% | +$21.5M | 0.12% | 205 |
|
|
2016
Q1 | $24.3M | Buy |
863,068
+234,376
| +37% | +$6.69M | 0.06% | 402 |
|
|
2015
Q4 | $19.3M | Sell |
628,692
-479,754
| -43% | -$15.1M | 0.04% | 588 |
|
|
2015
Q3 | $33M | Buy |
1,108,446
+1,078,006
| +3,541% | +$34.6M | 0.06% | 376 |
|
|
2015
Q2 | $968K | Sell |
30,440
-8,697,309
| -100% | -$283M | ﹤0.01% | 2304 |
|
|
2015
Q1 | $288M | Buy |
8,727,749
+5,038,347
| +137% | +$160M | 0.54% | 10 |
|
|
2014
Q4 | $109M | Buy |
3,689,402
+2,904,638
| +370% | +$83.3M | 0.23% | 60 |
|
|
2014
Q3 | $22M | Buy |
784,764
+54,950
| +8% | +$1.54M | 0.06% | 469 |
|
|
2014
Q2 | $20.6M | Sell |
729,814
-2,321,266
| -76% | -$66.2M | 0.06% | 469 |
|
|
2014
Q1 | $93M | Buy |
3,051,080
+1,041,831
| +52% | +$31.1M | 0.27% | 54 |
|
|
2013
Q4 | $58.4M | Buy |
2,009,249
+1,637,574
| +441% | +$47.7M | 0.18% | 92 |
|
|
2013
Q3 | $10.1M | Sell |
371,675
-1,041,637
| -74% | -$28.3M | 0.03% | 674 |
|
|
2013
Q2 | $37.6M | Buy |
+1,413,312
| New | +$39M | 0.12% | 130 |
|
Other funds holding PFE
VCM
VPM
Millennium Management's PFE Position: Q1 2026 in Review
Millennium Management reduced its Pfizer (PFE) stake by 95% in Q1 2026, selling an estimated $49.3M and leaving 96,364 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3575.
Millennium Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $557M in Q2 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Millennium Management held 96,364 shares of Pfizer worth $2.71M as of Q1 2026.
- Millennium Management sold 1,851,131 Pfizer shares in Q1 2026, an estimated $49.3M.
- Pfizer made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3575 holding.
- Millennium Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Pfizer position peaked at $557M in Q2 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.